Young patients with both type 1 diabetes mellitus and asthma have a unique IL-12 and IL-18 secretory pattern

Pediatric Diabetes

Volumn 12, Issue 7, 2011, Pages 596-603

  Rachmiel, Marianna ^a,b   Bloch, Olga ^a,b   Shaul, Aviv A ^a,b   Ben Yehudah, Gilad ^a,b   Bistritzer, Zvi ^a,b   Weintrob, Naomi ^b,c   Ofan, Regina ^b,c   Rapoport, Micha J ^a,b  

^a ASSAF HAROFEH MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c SCHNEIDER CHILDREN S MEDICAL CENTER OF ISRAEL   (Israel)

Author keywords

Asthma; IL 12; IL 18; T1DM

Indexed keywords

INTERLEUKIN 12; INTERLEUKIN 18;

ADOLESCENT; ADULT; ARTICLE; ASTHMA; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN CELL; IMMUNOMODULATION; IN VITRO STUDY; IN VIVO STUDY; INSULIN DEPENDENT DIABETES MELLITUS; LYMPHOCYTE PROLIFERATION; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; SCHOOL CHILD; TH1 CELL; TH2 CELL;

ADOLESCENT; ADULT; ASTHMA; CASE-CONTROL STUDIES; CELL PROLIFERATION; CHILD; DIABETES MELLITUS, TYPE 1; FEMALE; HUMANS; INTERLEUKIN-12; INTERLEUKIN-18; LEUKOCYTES, MONONUCLEAR; MALE; YOUNG ADULT;

EID: 80055075591     PISSN: 1399543X     EISSN: 13995448     Source Type: Journal    
DOI: 10.1111/j.1399-5448.2010.00751.x     Document Type: Article

References (42)

1. Almawi WY, Tamim H, Azar ST. Clinical review 103: T helper type 1 and 2 cytokines mediate the onset and progression of type I (insulin-dependent) diabetes. J Clin Endocrinol Metab 1999: 84: 1497-1502.
2. Mosmann TR, Sad S. The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol Today 1996: 17: 138-146.
3. Rachmiel M, Bloch O, Bistritzer T et al. TH1/TH2 cytokine balance in patients with both type 1 diabetes mellitus and asthma. Cytokine 2006: 34: 170-176.
4. Kainonen E, Rautava S, Korkeamaki M, Isolauri E. Unique cytokine secretion profile in children with both type I diabetes and asthma distinct from that of solely diabetic or asthmatic children. Cytokine 2006: 34: 198-205.
5. Nakanishi K, Yoshimoto T, Tsutsui H, Okamura H. Interleukin-18 is a unique cytokine that stimulates both Th1 and Th2 responses depending on its cytokine milieu. Cytokine Growth Factor Rev 2001: 12: 53-72.
6. Dong G, Liang L, Fu J, Zou C. Serum interleukin-18 levels are raised in diabetic ketoacidosis in Chinese children with type 1 diabetes mellitus. Indian Pediatr 2007: 44: 732-736.
7. Kaminski M, Kloda K, Pawlik A. [The role of interleukin-18 in the pathogenesis of bronchial asthma and other allergic diseases and in activation of basophils and mastocytes]. Pneumonol Alergol Pol 2008: 76: 432-436.
8. Yamagata S, Tomita K, Sato R, Niwa A, Higashino H, Tohda Y. Interleukin-18-deficient mice exhibit diminished chronic inflammation and airway remodelling in ovalbumin-induced asthma model. Clin Exp Immunol 2008: 154: 295-304.
9. Lukic ML, Mensah-Brown E, Wei X, Shahin A, Liew FY. Lack of the mediators of innate immunity attenuate the development of autoimmune diabetes in mice. J Autoimmun 2003: 21: 239-246.
10. Andre-Schmutz I, Hindelang C, Benoist C, Mathis D. Cellular and molecular changes accompanying the progression from insulitis to diabetes. Eur J Immunol 1999: 29: 245-255.
11. Hanifi-Moghaddam P, Schloot NC, Kappler S, Seissler J, Kolb H. An association of autoantibody status and serum cytokine levels in type 1 diabetes. Diabetes 2003: 52: 1137-1142.
12. Altinova AE, Yetkin I, Akbay E, Bukan N, Arslan M. Serum IL-18 levels in patients with type 1 diabetes: relations to metabolic control and microvascular complications. Cytokine 2008: 42: 217-221.
13. Tanaka H, Miyazaki N, Oashi K et al. IL-18 might reflect disease activity in mild and moderate asthma exacerbation. J Allergy Clin Immunol 2001: 107: 331-336.
14. Mahmoud RA, el-Ezz SA, Hegazy AS. Increased serum levels of interleukin-18 in patients with diabetic nephropathy. Ital J Biochem 2004: 53: 73-81.
15. Wild JS, Sigounas A, Sur N et al. IFN-gamma-inducing factor (IL-18) increases allergic sensitization, serum IgE, Th2 cytokines, and airway eosinophilia in a mouse model of allergic asthma. J Immunol 2000: 164: 2701-2710.
16. Gately MK, Renzetti LM, Magram J et al. The interleukin-12/interleukin-12-receptor system: role in normal and pathologic immune responses. Annu Rev Immunol 1998: 16: 495-521.
17. Rabinovitch A, Suarez-Pinzon WL, Sorensen O. Interleukin 12 mRNA expression in islets correlates with beta-cell destruction in NOD mice. J Autoimmun 1996: 9: 645-651.
18. Skarsvik S, Tiittanen M, Lindstrom A, Casas R, Ludvigsson J, Vaarala O. Poor in vitro maturation and pro-inflammatory cytokine response of dendritic cells in children at genetic risk of type 1 diabetes. Scand J Immunol 2004: 60: 647-652.
19. Zorena K, Mysliwska J, Mysliwiec M, Balcerska A, Lipowski P, Raczynska K. [Interleukin-12, vascular endothelial growth factor and tumor necrosis factor-alpha in the process of neoangiogenesis of diabetic retinopathy in children]. Klin Oczna 2007: 109: 155-159.
20. Gavett SH, O'Hearn DJ, Li X, Huang SK, Finkelman FD, Wills-Karp M. Interleukin 12 inhibits antigen-induced airway hyperresponsiveness, inflammation, and Th2 cytokine expression in mice. J Exp Med 1995: 182: 1527-1536.
21. Kips JC, Brusselle GJ, Joos GF et al. Interleukin-12 inhibits antigen-induced airway hyperresponsiveness in mice. Am J Respir Crit Care Med 1996: 153: 535-539.
22. Group NDD. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 1997: 28: 1039-1059.
23. Expert Panel Report II. Guidelines for the diagnosis and management of asthma. National asthma education and prevention program, 1997.
24. Rachmiel M, Bloch O, Bistritzer Z et al. Clinical characteristics and diabetes associated autoantibodies in patients with both type 1 diabetes mellitus and asthma. J Pediatr Endocrinol Metab 2006: 19: 1001-1006.
25. El-Mezzein RE, Matsumoto T, Nomiyama H, Miike T. Increased secretion of IL-18 in vitro by peripheral blood mononuclear cells of patients with bronchial asthma and atopic dermatitis. Clin Exp Immunol 2001: 126: 193-198.
26. Liu WD, Lu JR. [Serum levels of IL-12, TGFbeta1 and IgE in children with asthma]. Zhongguo Dang Dai Er Ke Za Zhi 2008: 10: 146-148.
27. Zorena K, Mysliwska J, Mysliwiec M, Balcerska A, Lipowski P, Raczynska K. Interleukin-12 and tumour necrosis factor-alpha equilibrium is a prerequisite for clinical course free from late complications in children with type 1 diabetes mellitus. Scand J Immunol 2008: 67: 204-208.
28. Cebeci AN, Nuhoglu Y, Arslanoglu I, Erguven M, Agachan N. The role of IL-18 in Th1/Th2 balance in children. Allergy Asthma Proc 2006: 27: 365-370.
29. Trembleau S, Germann T, Gately MK, Adorini L. The role of IL-12 in the induction of organ-specific autoimmune diseases. Immunol Today 1995: 16: 383-386.
30. Trembleau S, Penna G, Gregori S, Gately MK, Adorini L. Deviation of pancreas-infiltrating cells to Th2 by interleukin-12 antagonist administration inhibits autoimmune diabetes. Eur J Immunol 1997: 27: 2330-2339.
31. Trembleau S, Penna G, Gregori S et al. Pancreas-infiltrating Th1 cells and diabetes develop in IL-12-deficient nonobese diabetic mice. J Immunol 1999: 163: 2960-2968.
32. Bucks CM, Norton JA, Boesteanu AC, Mueller YM, Katsikis PD. Chronic antigen stimulation alone is sufficient to drive CD8+ T cell exhaustion. J Immunol 2009: 182: 6697-6708.
33. Karlsson MR, Rugtveit J, Brandtzaeg P. Allergen-responsive CD4+CD25+ regulatory T cells in children who have outgrown cow's milk allergy. J Exp Med 2004: 199: 1679-1688.
34. Mueller SN, Ahmed R. High antigen levels are the cause of T cell exhaustion during chronic viral infection. Proc Natl Acad Sci U S A 2009: 106: 8623-8628.
35. Pop SM, Wong CP, Culton DA, Clarke SH, Tisch R. Single cell analysis shows decreasing FoxP3 and TGFbeta1 coexpressing CD4+CD25+ regulatory T cells during autoimmune diabetes. J Exp Med 2005: 201: 1333-1346.
36. Macatonia SE, Hosken NA, Litton M et al. Dendritic cells produce IL-12 and direct the development of Th1 cells from naive CD4+ T cells. J Immunol 1995: 154: 5071-5079.
37. Chang CC, Wright A, Punnonen J. Monocyte-derived CD1a+ and CD1a- dendritic cell subsets differ in their cytokine production profiles, susceptibilities to transfection, and capacities to direct Th cell differentiation. J Immunol 2000: 165: 3584-3591.
38. Okamoto I, Kohno K, Tanimoto T, Ikegami H, Kurimoto M. Development of CD8+ effector T cells is differentially regulated by IL-18 and IL-12. J Immunol 1999: 162: 3202-3211.
39. Dinarello CA. IL-18: A TH1-inducing, proinflammatory cytokine and new member of the IL-1 family. J Allergy Clin Immunol 1999: 103: 11-24.
40. Nakahira M, Ahn HJ, Park WR et al. Synergy of IL-12 and IL-18 for IFN-gamma gene expression: IL-12-induced STAT4 contributes to IFN-gamma promoter activation by up-regulating the binding activity of IL-18-induced activator protein 1. J Immunol 2002: 168: 1146-1153.
41. Yoshimoto T, Tsutsui H, Tominaga K et al. IL-18, although antiallergic when administered with IL-12, stimulates IL-4 and histamine release by basophils. Proc Natl Acad Sci U S A 1999: 96: 13962-13966.
42. Ishikawa Y, Yoshimoto T, Nakanishi K. Contribution of IL-18-induced innate T cell activation to airway inflammation with mucus hypersecretion and airway hyperresponsiveness. Int Immunol 2006: 18: 847-855.